Nosebleed recurrence prognostic factors
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
DOI: | 10.34631/sporl.387 |
Texto Completo: | https://doi.org/10.34631/sporl.387 |
Resumo: | Objectives: To evaluate nosebleed recurrence prognostic factors.Study Design: Retrospective observational studyMaterial e Methods: Inclusion criteria was nosebleed in ENT emergency department in 2013. Correlation with recurrence was tested for pathologic factors, nosebleed characteristics, treatment methods, seasonality, climacteric conditions, demographic factors, recommendations and hospital admittance need.Results: We observed 549 nosebleed episodes from 396 patients with 27.9% recurrence episodes. In 17.3% patients were prescribed anticoagulants; 39.3% the nosebleed was active in the ED and hospital admittance was necessary in 9.8%. Recurrence prognostic factors included, anticoagulant medication, active nosebleed, coagulation disorders and smoking. Hospital admittance was a recurrence protective factor. No association between recurrence and any of the used techniques was identified.Conclusions: Nosebleed recurrence negative prognostic factors included anticoagulant use, previous coagulation disorders, active nosebleed and active smoking. Hospital admittance was a positive prognostic factor. It’s of utmost importance to have them in consideration during nosebleed management. |
id |
RCAP_1efcff358d3ac6386bf5954ac884d44d |
---|---|
oai_identifier_str |
oai:journalsporl.com:article/2810 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Nosebleed recurrence prognostic factorsFactores De Prognóstico De Recidiva Na EpistáxisNosebleedrecurrenceprognostic factorsEpistáxisrecidivafactores prognósticosObjectives: To evaluate nosebleed recurrence prognostic factors.Study Design: Retrospective observational studyMaterial e Methods: Inclusion criteria was nosebleed in ENT emergency department in 2013. Correlation with recurrence was tested for pathologic factors, nosebleed characteristics, treatment methods, seasonality, climacteric conditions, demographic factors, recommendations and hospital admittance need.Results: We observed 549 nosebleed episodes from 396 patients with 27.9% recurrence episodes. In 17.3% patients were prescribed anticoagulants; 39.3% the nosebleed was active in the ED and hospital admittance was necessary in 9.8%. Recurrence prognostic factors included, anticoagulant medication, active nosebleed, coagulation disorders and smoking. Hospital admittance was a recurrence protective factor. No association between recurrence and any of the used techniques was identified.Conclusions: Nosebleed recurrence negative prognostic factors included anticoagulant use, previous coagulation disorders, active nosebleed and active smoking. Hospital admittance was a positive prognostic factor. It’s of utmost importance to have them in consideration during nosebleed management.Objectivos: Avaliar os factores clínicos prognósticos de recidiva de epistáxis.Desenho do estudo: Estudo retrospectivo.Materiais e Métodos: Foram incluídos os doentes que recorreram ao SU-CHUC no ano 2013 por epistáxis. Foi testada a correlação entre recidiva de epistáxis e antecedentes pessoais, características da epistáxis, métodos de tratamento, sazonalidade, clima, demografia, recomendações pós-alta e internamento.Resultados: Observaram-se 549 episódios de 396 doentes com 27.9% de episódios de recidiva. Verificou-se anticoagulação em 17,3%, epistáxis activa em 39,3% e internamento em 9,8%.Foram identificados como factores prognósticos de maior recidiva de epistáxis a anticoagulação, epistáxis activa, coagulopatia e tabagismo. O internamento foi um factor protector de recidiva. Não houve associação entre recidiva e nenhuma das técnicas utilizadas.Conclusões: A anticoagulação, coagulopatia, epistáxis activa e tabagismo activo foram identificados como factores predisponentes e o internamento como factor protector. É importante conhecer os factores de risco hemorrágico na orientação terapêutica da epistáxis.Sociedade Portuguesa de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço2017-05-07info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documenthttps://doi.org/10.34631/sporl.387https://doi.org/10.34631/sporl.387Portuguese Journal of Otorhinolaryngology and Head and Neck Surgery; Vol. 54 No. 2 (2016): Junho; 119-124Revista Portuguesa de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço; Vol. 54 Núm. 2 (2016): Junho; 119-124Revista Portuguesa de Otorrinolaringologia-Cirurgia de Cabeça e Pescoço; Vol. 54 N.º 2 (2016): Junho; 119-1242184-6499reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://journalsporl.com/index.php/sporl/article/view/2810https://journalsporl.com/index.php/sporl/article/view/2810/824https://journalsporl.com/index.php/sporl/article/view/2810/825Laffont, JoãoMelo, Ana SofiaCaiado, RicardoCasalta, JoãoRibeiro, João CarlosRibeiro, CarlosPaiva, António Diogoinfo:eu-repo/semantics/openAccess2024-06-06T13:00:19Zoai:journalsporl.com:article/2810Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-06-06T13:00:19Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Nosebleed recurrence prognostic factors Factores De Prognóstico De Recidiva Na Epistáxis |
title |
Nosebleed recurrence prognostic factors |
spellingShingle |
Nosebleed recurrence prognostic factors Nosebleed recurrence prognostic factors Laffont, João Nosebleed recurrence prognostic factors Epistáxis recidiva factores prognósticos Laffont, João Nosebleed recurrence prognostic factors Epistáxis recidiva factores prognósticos |
title_short |
Nosebleed recurrence prognostic factors |
title_full |
Nosebleed recurrence prognostic factors |
title_fullStr |
Nosebleed recurrence prognostic factors Nosebleed recurrence prognostic factors |
title_full_unstemmed |
Nosebleed recurrence prognostic factors Nosebleed recurrence prognostic factors |
title_sort |
Nosebleed recurrence prognostic factors |
author |
Laffont, João |
author_facet |
Laffont, João Laffont, João Melo, Ana Sofia Caiado, Ricardo Casalta, João Ribeiro, João Carlos Ribeiro, Carlos Paiva, António Diogo Melo, Ana Sofia Caiado, Ricardo Casalta, João Ribeiro, João Carlos Ribeiro, Carlos Paiva, António Diogo |
author_role |
author |
author2 |
Melo, Ana Sofia Caiado, Ricardo Casalta, João Ribeiro, João Carlos Ribeiro, Carlos Paiva, António Diogo |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Laffont, João Melo, Ana Sofia Caiado, Ricardo Casalta, João Ribeiro, João Carlos Ribeiro, Carlos Paiva, António Diogo |
dc.subject.por.fl_str_mv |
Nosebleed recurrence prognostic factors Epistáxis recidiva factores prognósticos |
topic |
Nosebleed recurrence prognostic factors Epistáxis recidiva factores prognósticos |
description |
Objectives: To evaluate nosebleed recurrence prognostic factors.Study Design: Retrospective observational studyMaterial e Methods: Inclusion criteria was nosebleed in ENT emergency department in 2013. Correlation with recurrence was tested for pathologic factors, nosebleed characteristics, treatment methods, seasonality, climacteric conditions, demographic factors, recommendations and hospital admittance need.Results: We observed 549 nosebleed episodes from 396 patients with 27.9% recurrence episodes. In 17.3% patients were prescribed anticoagulants; 39.3% the nosebleed was active in the ED and hospital admittance was necessary in 9.8%. Recurrence prognostic factors included, anticoagulant medication, active nosebleed, coagulation disorders and smoking. Hospital admittance was a recurrence protective factor. No association between recurrence and any of the used techniques was identified.Conclusions: Nosebleed recurrence negative prognostic factors included anticoagulant use, previous coagulation disorders, active nosebleed and active smoking. Hospital admittance was a positive prognostic factor. It’s of utmost importance to have them in consideration during nosebleed management. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-05-07 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.34631/sporl.387 https://doi.org/10.34631/sporl.387 |
url |
https://doi.org/10.34631/sporl.387 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://journalsporl.com/index.php/sporl/article/view/2810 https://journalsporl.com/index.php/sporl/article/view/2810/824 https://journalsporl.com/index.php/sporl/article/view/2810/825 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/vnd.openxmlformats-officedocument.wordprocessingml.document |
dc.publisher.none.fl_str_mv |
Sociedade Portuguesa de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço |
publisher.none.fl_str_mv |
Sociedade Portuguesa de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço |
dc.source.none.fl_str_mv |
Portuguese Journal of Otorhinolaryngology and Head and Neck Surgery; Vol. 54 No. 2 (2016): Junho; 119-124 Revista Portuguesa de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço; Vol. 54 Núm. 2 (2016): Junho; 119-124 Revista Portuguesa de Otorrinolaringologia-Cirurgia de Cabeça e Pescoço; Vol. 54 N.º 2 (2016): Junho; 119-124 2184-6499 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
mluisa.alvim@gmail.com |
_version_ |
1822183192327618560 |
dc.identifier.doi.none.fl_str_mv |
10.34631/sporl.387 |